Astrana Health, Inc.

Astrana Health, Inc.

ASTHNYSE / NASDAQHealthcareSmall cap

$28.90+$0.22 (+0.8%)

Last close · Data as of Nov 20, 2026

Market cap
$1.9B
P/E
83.5x
EV / EBITDA
18.7x
Revenue
$3.2B
Net margin
0.7%
ROCE
4.9%

+42.1% over the last year

Astrana Health, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-25.1%
3M
-25.4%
6M
-25.4%
1Y
+42.1%
5Y
-74.5%

52-week range

Day change +$0.22 (+0.8%) from $29 to $29 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in ASTH, bought on each weekday since 2021.

News & filings

What Astrana Health filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthRevenue grew 56.4% in fiscal 2025.

Concerns (1)

  • Operating profit was 1.8 times interest costs.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Read moreShow less

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Sector
Healthcare
Shares outstanding
48.9M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$1.9B
P/E
83.5x
P/B
2.4x
EV / EBITDA
18.7x
EV / Sales
0.8x
P/S
0.6x
52-week high
$49.81
52-week low
$18.16

Profitability

Operating margin
2.5%
Net margin
0.7%
EBITDA margin
4.3%
ROE
2.9%
ROCE
4.9%
ROA
1.0%
Asset turnover
1.43

Growth

Revenue
$3.2B
Revenue growth, 1Y
56.4%
Revenue CAGR, 3Y
40.6%
Net profit growth, 1Y
-47.9%
Free cash flow
$104.5M

Solvency

Current ratio
1.40
Debt / Equity
1.38
Debt / Assets
0.49
CFO / Net profit
5.10
Cash / Market cap
22.9%

Where the revenue went

Of every $100 of FY2025 revenue, $1 was left as net income.

Astrana Health, Inc. income statement flow, FY2025
Astrana Health, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$2.8B
RevenueGross profit$341.5M
Gross profitSelling, general and administrative$217.3M
Gross profitOther operating expenses$45.7M
Gross profitOperating income$78.5M
Operating incomePretax income$39.6M
Operating incomeInterest and other expense$38.9M
Pretax incomeTax and other$17.1M
Pretax incomeNet income$22.5M

Revenue and net profit

Revenue grew 56.4% in FY2025; net profit is the dashed line.

Astrana Health, Inc. revenue and net profit by fiscal year
Astrana Health, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$1.1B$45.2M
FY2023$1.4B$60.7M
FY2024$2.0B$43.1M
FY2025$3.2B$22.5M

Cash flows

FY2025: $114.6M from operations, $104.5M free after investment (dashed).

Astrana Health, Inc. operating and free cash flow by fiscal year
Astrana Health, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$82.1M$59.2M
FY2023$68.2M$39.7M
FY2024$52.2M$44.2M
FY2025$114.6M$104.5M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$3.2B+56.4%1Y
EBITDA
$135.3M-4.6%1Y
Net profit
$22.5M-47.9%1Y
Cash from operations
$114.6M+119.5%1Y
Free cash flow
$104.5M+136.6%1Y
Revenue CAGR, 3Y
40.6%
Net profit CAGR, 3Y
-20.7%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$3.2B$135.3M$22.5M$104.5M2.9%+56.4%-47.9%

Monthly returns

Month-by-month returns of ASTH across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$2.2B
Liabilities$1.7B
Equity$558.3M
Paid-in capital$470.9M
Retained earnings$308.4M
Minority interest-$221.0M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; ASTH highlighted.

P/E against peers

ASTH trades at 83.5x earnings against a peer median of -10.7x.

  1. Astrana Health, Inc. (this company)83.5x

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Astrana Health, Inc.ASTHthis company$1.9B83.5x2.4x2.9%18.7x
Ocular Therapeutix, Inc.OCUL$1.9B-7.2x2.9x-40.6%-5.1x
Harmony Biosciences Holdings, Inc.HRMY$1.9B12.0x2.2x18.2%5.2x
Stoke Therapeutics, Inc.STOK$1.9B-272.5x5.3x-2.0%-95.4x
Pulse Biosciences, Inc.PLSE$1.9B-25.6x23.1x-90.2%-23.6x
Zymeworks Inc.ZYME$1.8B-22.8x6.9x-30.2%-22.4x
Maravai LifeSciences Holdings, Inc.MRVI$1.8B-14.1x8.7x-61.6%-13.5x
Pediatrix Medical Group, Inc.MD$1.8B11.1x2.1x19.1%7.6x
Viridian Therapeutics, Inc.VRDN$1.8B-5.3x3.1x-58.1%-4.9x
Peer median—-10.7x4.2x-35.4%-9.3x

Year-to-date ROI

ASTH since 1 January, against earlier years.

Historical volatility

ASTH's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Astrana Health, Inc. operating margin by fiscal year
Astrana Health, Inc. operating margin by fiscal year
DateOperating margin
FY20229.1%
FY20236.1%
FY20244.4%
FY20252.5%
LineFY2025
Cost of revenueCost Of Revenue$2.8B
Gross profitGross Profit$341.5M
Operating expensesOperating Expense$263.0M
Other operating expensesOther Operating Expenses—
Depreciation and amortisationDepreciation And Amortization In Income Statement$45.8M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$45.8M
Provision for doubtful accountsProvision For Doubtful Accounts—
Total expensesTotal Expenses$3.1B
Pretax incomePretax Income$39.6M

Learn while you research

Academy chapters picked for Astrana Health, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Valuation Multiples ExplainedThis stock trades at a P/E of 83.5, learn when high multiples are justified.6 min read
  3. 03 Growth Investing56% revenue growth is in the top tier, learn how to value growth.7 min read
  4. 04 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  5. 05 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  6. 06 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
Browse the full Equiscale Academy →